What Can Diabetes-Associated Genetic Variation in TCF7L2 Teach Us About the Pathogenesis of Type 2 Diabetes?

被引:10
作者
Adams, J. D. [1 ]
Vella, Adrian [1 ]
机构
[1] Mayo Clin, Coll Med, Endocrine Res Unit, Dept Endocrinol Diabet & Nutr, 200 First St SW,Rm 5-194 Joseph, Rochester, MN 55905 USA
基金
美国国家卫生研究院;
关键词
common genetic variation; insulin secretion; insulin action; type; 2; diabetes; PATHWAY EFFECTOR TCF7L2; INSULIN-SECRETION; BETA-CATENIN; SUSCEPTIBILITY GENE; GLUCOSE-METABOLISM; PROGLUCAGON GENE; CELL FUNCTION; WNT; POLYMORPHISMS; EXPRESSION;
D O I
10.1089/met.2018.0024
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Type 2 diabetes mellitus (T2DM) is a polygenic metabolic disorder characterized by hyperglycemia occurring as a result of impaired insulin secretion and/or insulin resistance. Among the various genetic factors associated with T2DM, a common genetic variant within the transcription factor 7-like 2 locus (TCF7L2) confers the greatest genetic risk for development of the disease. However, the mechanism(s) by which TCF7L2 predisposes to diabetes remain uncertain. Here we review the current literature pertaining to the potential mechanisms by which TCF7L2 confers risk of T2DM, using genetic variation as a probe to understand the pathogenesis of the disease.
引用
收藏
页码:383 / 389
页数:7
相关论文
共 50 条
[21]   Worldwide Distribution of Type II Diabetes-Associated TCF7L2 SNPs: Evidence for Stratification in Europe [J].
Guinan, Kieran J. .
BIOCHEMICAL GENETICS, 2012, 50 (3-4) :159-179
[22]   The new type 2 diabetes gene TCF7L2 [J].
Florez, Jose C. .
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2007, 10 (04) :391-396
[23]   TCF7L2 polymorphisms are associated with type 2 diabetes in Khatri Sikhs from North India:: Genetic variation affects lipid levels [J].
Sanghera, D. K. ;
Nath, S. K. ;
Ortega, L. ;
Gambarelli, M. ;
Kim-Howard, X. ;
Singh, J. R. ;
Ralhan, S. K. ;
Wander, G. S. ;
Mehra, N. K. ;
Mulvihill, J. J. ;
Kamboh, M. I. .
ANNALS OF HUMAN GENETICS, 2008, 72 :499-509
[24]   Association of TCF7L2 polymorphisms with type 2 diabetes in Mexico City [J].
Parra, E. J. ;
Cameron, E. ;
Simmonds, L. ;
Valladares, A. ;
McKeigue, P. ;
Shriver, M. ;
Wacher, N. ;
Kumate, J. ;
Kittles, R. ;
Cruz, M. .
CLINICAL GENETICS, 2007, 71 (04) :359-366
[25]   TCF7L2 is associated with type 2 diabetes in nonobese individuals from Tunisia [J].
Bouhaha, R. ;
Choquet, H. ;
Meyre, D. ;
Kamoun, H. Abid ;
Ennafaa, H. ;
Baroudi, T. ;
Sassi, R. ;
Vaxillaire, M. ;
Elgaaied, A. ;
Froguel, P. ;
Cauchi, S. .
PATHOLOGIE BIOLOGIE, 2010, 58 (06) :426-429
[26]   The involvement of the wnt signaling pathway and TCF7L2 in diabetes mellitus: The current understanding, dispute, and perspective [J].
Ip, Wilfred ;
Chiang, Yu-ting Alex ;
Jin, Tianru .
CELL AND BIOSCIENCE, 2012, 2
[27]   Novel TCF7L2 familial linkage and association with Type 2 diabetes, depression, and their comorbidity [J].
Del Bosque-plata, L. ;
Amin, M. ;
Wu, R. ;
Postolache, T. T. ;
Gragnoli, C. .
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (02) :694-703
[28]   TCF7L2 polymorphisms are associated with type 2 diabetes in northern Sweden [J].
Sofia Mayans ;
Kurt Lackovic ;
Petter Lindgren ;
Karin Ruikka ;
Åsa Ågren ;
Mats Eliasson ;
Dan Holmberg .
European Journal of Human Genetics, 2007, 15 :342-346
[29]   TCF7L2 and type 2 diabetes—we WNT to know [J].
U. Smith .
Diabetologia, 2007, 50 :5-7
[30]   TCF7L2 polymorphisms are associated with type 2 diabetes in northern Sweden [J].
Mayans, Sofia ;
Lackovic, Kurt ;
Lindgren, Petter ;
Ruikka, Karin ;
Agren, Asa ;
Eliasson, Mats ;
Holmberg, Dan .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2007, 15 (03) :342-346